XML 40 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-Based Compensation (Tables)
9 Months Ended
Oct. 27, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-Based Compensation Expense

Share-based compensation expense was recognized as follows:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

(In thousands)

 

October 27,

2018

 

 

October 28,

2017

 

 

October 27,

2018

 

 

October 28,

2017

 

Stock Options

 

$

215

 

 

$

105

 

 

$

571

 

 

$

316

 

Restricted Stock Awards and Restricted Stock Units

 

 

290

 

 

 

436

 

 

 

757

 

 

 

800

 

Employee Stock Purchase Plan

 

 

5

 

 

 

3

 

 

 

11

 

 

 

9

 

Total

 

$

510

 

 

$

544

 

 

$

1,339

 

 

$

1,125

 

 

Fair Value of Stock Options Granted

The fair value of stock options granted during the nine months ended October 27, 2018 and October 28, 2017 was estimated using the following assumptions:

 

 

 

Nine Months Ended

 

 

 

October 27,

2018

 

 

October 28,

2017

 

Risk Free Interest Rate

 

 

2.6

%

 

 

1.7

%

Expected Volatility

 

 

39.3

%

 

 

37.9

%

Expected Life (in years)

 

 

9.0

 

 

 

8.0

 

Dividend Yield

 

 

1.5

%

 

 

2.2

%

 

Aggregated Information Regarding Stock Options Granted

Aggregated information regarding stock options granted under the Plans for the nine months ended October 27, 2018, is summarized below:

 

 

 

Number of

Options

 

 

Weighted

Average

Exercise Price

 

Outstanding at January 31, 2018

 

 

745,270

 

 

$

12.52

 

Granted

 

 

196,000

 

 

 

18.21

 

Exercised

 

 

(144,875

)

 

 

10.65

 

Forfeited

 

 

(11,250

)

 

 

14.61

 

Canceled

 

 

(3,700

)

 

 

8.95

 

Outstanding at October 27, 2018

 

 

781,445

 

 

$

14.28

 

 

Summary of Options Outstanding

Set forth below is a summary of options outstanding at October 27, 2018:

 

 

Outstanding

 

 

Exercisable

 

Range of

Exercise prices

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Life

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life

 

$

5.00-10.00

 

 

78,181

 

 

$

7.71

 

 

 

2.8

 

 

 

78,181

 

 

$

7.71

 

 

 

2.8

 

$

10.01-15.00

 

 

457,664

 

 

$

13.65

 

 

 

7.1

 

 

 

302,497

 

 

$

13.65

 

 

 

6.4

 

$

15.01-20.00

 

 

245,600

 

 

$

17.56

 

 

 

9.1

 

 

 

30,000

 

 

$

15.17

 

 

 

7.7

 

 

 

 

 

781,445

 

 

$

14.28

 

 

 

7.3

 

 

 

410,678

 

 

$

12.63

 

 

 

5.8

 

 

Aggregated Information Regarding RSUs and RSAs Granted

Aggregated information regarding RSUs and RSAs granted under the Plans for the nine months ended October 27, 2018 is summarized below:

 

 

 

RSAs & RSUs

 

 

Weighted

Average

Grant Date

Fair Value

 

Unvested at January 31, 2018

 

$

177,347

 

 

$

13.99

 

Granted

 

 

101,764

 

 

 

17.80

 

Vested

 

 

(52,371

)

 

 

14.35

 

Forfeited

 

 

(82,672

)

 

 

14.05

 

Unvested at October 27, 2018

 

$

144,068

 

 

$

16.53